|
23 Mar 2007 |
Æterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
|
|
22 Mar 2007 |
BioGeneriX and Neose Announce Initiation of 2nd Phase I Clinical Trial of GlycoPEG-GCSF; Interim Results From 1st Phase I Trial Show Dose-Dependent Response
|
|
22 Mar 2007 |
BioLineRx In-Licenses Novel Peptide for the Treatment of Inflammatory Diseases
|
|
21 Mar 2007 |
Talecris Initiates Clinical Development Program Evaluating Plasmin for Dissolving Blood Clots and Restoring Blood Flow in Legs
|
|
21 Mar 2007 |
Radius Begins Phase II Clinical Trial of BA058 for Osteoporosis
|
|
21 Mar 2007 |
Potentia Pharmaceuticals Announces Initiation of Phase I Clinical Trials to Evaluate its Lead Compound for Age-Related Macular Degeneration
|
|
16 Mar 2007 |
Affibody to publish data on therapeutic effects of Affibody(R) molecules in a cancer model
|
|
16 Mar 2007 |
Aida Pharmaceuticals Initiates Preclinical Research of Potential Anti-Cancer Treatment Vasostatin-Apo2L
|
|
16 Mar 2007 |
Neose Receives FDA Clearance to Commence U.S. Clinical Trials for NE-180
|
|
16 Mar 2007 |
Pacgen completes patient recruitment for Phase I/II trial of novel anti-fungal drug
|
|
15 Mar 2007 |
Lev Pharmaceuticals, Inc. Reports Positive Results in Pivotal Phase III Trial for Hereditary Angioedema
|
|
14 Mar 2007 |
Ambrilia and Mallinckrodt Announce IND Filing for Phase III Clinical Study of Improved Octreotide Formulation
|
|
14 Mar 2007 |
Maxygen Announces End of Co-Development Agreement
|
|
13 Mar 2007 |
Cangene Receives an Approvable Letter From the FDA for Human Growth Hormone
|
|
13 Mar 2007 |
Chemokine Therapeutics Announces Preliminary Results of CTCE-9908 Phase IB/II Clinical Trial in Late Stage Cancer Patients
|
|
10 Mar 2007 |
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
|
|
09 Mar 2007 |
Data From Adherex's European Phase Ib/II Trial of ADH-1 to be Presented at International Symposium on Targeted Anticancer Therapies
|
|
09 Mar 2007 |
Alba Announces Completion of Enrollment and Dosing of Patients in Phase II Clinical Trial of AT-1001 for the Treatment of Celiac Disease
|
|
08 Mar 2007 |
ZymoGenetics Provides Update on rhThrombin Development Plans
|
|
08 Mar 2007 |
Allon product AL-108 successful in Phase Ib clinical trial
|
|
07 Mar 2007 |
Clinquest Group and TNO sign licensing agreement on protein for inflammatory disorders
|
|
07 Mar 2007 |
AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy
|
|
07 Mar 2007 |
Nautilus Biotech and HanAll Pharmaceutical announce license agreement to develop three Nautilus Biotech products in South Korea
|
|
06 Mar 2007 |
Cytheris Releases Promising Clinical Data on its Interleukin-7 Immune Enhancer at the 2007 CROI Meeting in Los Angeles
|
|
06 Mar 2007 |
Transition Therapeutics Announces Positive Data from E1-I.N.T.(TM) Clinical Trials in Type 1 and Type 2 Diabetes Patients
|
